654 related articles for article (PubMed ID: 19179848)
1. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
Gardier AM
Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
[TBL] [Abstract][Full Text] [Related]
2. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
Kozisek ME; Middlemas D; Bylund DB
Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
6. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
[TBL] [Abstract][Full Text] [Related]
7. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats.
Tamburella A; Micale V; Navarria A; Drago F
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1205-10. PubMed ID: 19596038
[TBL] [Abstract][Full Text] [Related]
9. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice.
Hill RA; Murray SS; Halley PG; Binder MD; Martin SJ; van den Buuse M
Hippocampus; 2011 Apr; 21(4):434-45. PubMed ID: 20087884
[TBL] [Abstract][Full Text] [Related]
11. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
12. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
Lucki I
J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
[TBL] [Abstract][Full Text] [Related]
13. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus.
Deltheil T; Guiard BP; Guilloux JP; Nicolas L; Deloménie C; Repérant C; Le Maitre E; Leroux-Nicollet I; Benmansour S; Coudoré F; David DJ; Gardier AM
Pharmacol Biochem Behav; 2008 Aug; 90(2):174-83. PubMed ID: 17980409
[TBL] [Abstract][Full Text] [Related]
14. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains.
Naumenko VS; Kondaurova EM; Bazovkina DV; Tsybko AS; Tikhonova MA; Kulikov AV; Popova NK
Neuroscience; 2012 Jul; 214():59-67. PubMed ID: 22531372
[TBL] [Abstract][Full Text] [Related]
15. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
Stahl S
Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
[TBL] [Abstract][Full Text] [Related]
16. Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor.
Mao QQ; Ip SP; Ko KM; Tsai SH; Che CT
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1211-6. PubMed ID: 19596036
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine exerts antidepressant-like effects in animal models: role of brain-derived neurotrophic factor.
Gao S; Cui YL; Yu CQ; Wang QS; Zhang Y
Behav Brain Res; 2013 Feb; 238():79-85. PubMed ID: 23085478
[TBL] [Abstract][Full Text] [Related]
18. [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies].
Adrien J
J Soc Biol; 2004; 198(1):30-6. PubMed ID: 15146953
[TBL] [Abstract][Full Text] [Related]
19. A silver bullet for the treatment of depression?
Duman RS
Neuron; 2007 Sep; 55(5):679-81. PubMed ID: 17785173
[TBL] [Abstract][Full Text] [Related]
20. The P11, tPA/plasminogen system and brain-derived neurotrophic factor: Implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.
Tsai SJ
Med Hypotheses; 2007; 68(1):180-3. PubMed ID: 16890384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
